Brokerages Expect The Cooper Companies, Inc. (NYSE:COO) Will Post Earnings of $3.37 Per Share

Brokerages expect The Cooper Companies, Inc. (NYSE:COO) to announce earnings per share of $3.37 for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have made estimates for Cooper Companies’ earnings, with the highest EPS estimate coming in at $3.39 and the lowest estimate coming in at $3.34. Cooper Companies reported earnings of $3.16 per share in the same quarter last year, which would suggest a positive year over year growth rate of 6.6%. The company is scheduled to issue its next earnings report after the market closes on Thursday, December 2nd.

On average, analysts expect that Cooper Companies will report full-year earnings of $13.33 per share for the current fiscal year, with EPS estimates ranging from $13.30 to $13.35. For the next fiscal year, analysts anticipate that the business will post earnings of $14.55 per share, with EPS estimates ranging from $14.30 to $14.77. Zacks Investment Research’s EPS averages are an average based on a survey of sell-side research analysts that that provide coverage for Cooper Companies.

Cooper Companies (NYSE:COO) last issued its earnings results on Wednesday, September 1st. The medical device company reported $3.41 earnings per share for the quarter, topping analysts’ consensus estimates of $3.29 by $0.12. The firm had revenue of $763.40 million during the quarter, compared to analyst estimates of $727.30 million. Cooper Companies had a net margin of 102.48% and a return on equity of 11.42%. The company’s quarterly revenue was up 32.0% on a year-over-year basis. During the same quarter last year, the business earned $2.28 earnings per share.

A number of equities analysts have weighed in on COO shares. Robert W. Baird reiterated a “hold” rating and set a $423.00 target price on shares of Cooper Companies in a research report on Friday, September 3rd. Oppenheimer raised their price objective on shares of Cooper Companies from $405.00 to $475.00 and gave the company an “outperform” rating in a research report on Friday, September 3rd. Piper Sandler raised their price objective on shares of Cooper Companies from $440.00 to $460.00 and gave the company an “overweight” rating in a research report on Friday, August 6th. Wells Fargo & Company raised their price objective on shares of Cooper Companies from $445.00 to $480.00 and gave the company an “overweight” rating in a research report on Thursday, August 19th. Finally, Citigroup raised their price objective on shares of Cooper Companies from $400.00 to $453.00 and gave the company a “neutral” rating in a research report on Friday, September 3rd. Two analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and an average target price of $432.23.

NYSE:COO traded down $7.60 on Thursday, reaching $390.84. 327,117 shares of the company’s stock were exchanged, compared to its average volume of 266,070. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.39 and a quick ratio of 0.83. The firm has a market cap of $19.27 billion, a price-to-earnings ratio of 6.66, a P/E/G ratio of 2.52 and a beta of 0.83. Cooper Companies has a 52 week low of $324.34 and a 52 week high of $463.59. The stock has a fifty day simple moving average of $416.45 and a 200-day simple moving average of $412.32.

In other Cooper Companies news, COO Daniel G. Mcbride sold 72,624 shares of Cooper Companies stock in a transaction that occurred on Tuesday, September 7th. The shares were sold at an average price of $450.13, for a total transaction of $32,690,241.12. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Gary S. Petersmeyer sold 1,800 shares of the firm’s stock in a transaction that occurred on Wednesday, September 15th. The stock was sold at an average price of $440.73, for a total transaction of $793,314.00. The disclosure for this sale can be found here. Insiders sold 79,387 shares of company stock worth $35,732,390 over the last ninety days. 1.70% of the stock is currently owned by insiders.

A number of large investors have recently added to or reduced their stakes in the stock. FMR LLC boosted its holdings in shares of Cooper Companies by 47.6% during the 2nd quarter. FMR LLC now owns 182,951 shares of the medical device company’s stock valued at $72,498,000 after buying an additional 58,977 shares in the last quarter. Victory Capital Management Inc. boosted its holdings in shares of Cooper Companies by 3.5% during the 2nd quarter. Victory Capital Management Inc. now owns 775,553 shares of the medical device company’s stock valued at $307,328,000 after buying an additional 26,164 shares in the last quarter. Bellevue Group AG boosted its holdings in shares of Cooper Companies by 7.1% during the 2nd quarter. Bellevue Group AG now owns 74,266 shares of the medical device company’s stock valued at $29,429,000 after buying an additional 4,899 shares in the last quarter. Panagora Asset Management Inc. boosted its holdings in shares of Cooper Companies by 170.2% during the 2nd quarter. Panagora Asset Management Inc. now owns 13,598 shares of the medical device company’s stock valued at $5,388,000 after buying an additional 8,566 shares in the last quarter. Finally, Commonwealth Equity Services LLC boosted its holdings in shares of Cooper Companies by 12.6% during the 2nd quarter. Commonwealth Equity Services LLC now owns 4,088 shares of the medical device company’s stock valued at $1,620,000 after buying an additional 459 shares in the last quarter. Institutional investors and hedge funds own 96.89% of the company’s stock.

Cooper Companies Company Profile

The Cooper Cos, Inc operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues.

Further Reading: Price-Sales Ratio

Get a free copy of the Zacks research report on Cooper Companies (COO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.